Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major

Immunology

Volumn 105, Issue 4, 2002, Pages 515-523

  Yamakami, Kazuo ^a   Akao, Shinkichi ^a   Tadakuma, Takushi ^a   Nitta, Yoshio ^b   Miyazaki, Jyun Ichi ^b   Yoshizawa, Nobuyuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EXPERIMENTAL INFECTION; FEMALE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; FEMALE; INJECTIONS, INTRADERMAL; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PLASMIDS; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 0036232140     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01394.x     Document Type: Article

References (41)

1. The expanding universe of T-cell subsets: Th1, Th2 and more
2. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major
3. Leishmania major infection in interleukin-4 and interferon-γ depleted mice
4. The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis
5. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice
6. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major
7. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance
8. + T cell differentiation
9. + T cells
10. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice
11. The antigen dose determines T helper subset development by regulation of CD40 ligand
12. Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses
13. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major
14. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model
15. Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice
16. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite
17. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
18. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
19. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primarily T cell proliferation in vitro
20. Early in vitro priming of distinct Th cell subsets determines polarized growth of visceralizing Leishmania in macrophages
21. Cytokine regulation of murine leishmaniasis: Interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice
22. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response
23. + T cells during initiation of infection
24. + T cells which are NK1.1
25. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness
26. + effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major
27. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism
28. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo
29. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice
30. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
31. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice
32. Experimental Leishmania major infection: Role of IL-10
33. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo
34. Manipulation of the immune response to plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
35. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
36. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice
37. Stability of Th1 and Th2 populations
38. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation
39. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-γ and nitric oxide synthetase 2
40. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
41. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development